How many clinical trials are studying Exemestane 25 MG?

3 recruiting trials in our tracked data involve Exemestane 25 MG.

What conditions is Exemestane 25 MG being studied for?

In our tracked recruiting trials, Exemestane 25 MG is being studied in trials for Breast Cancer, Breast Cancer Metastatic, ER-positive Breast Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 1 Phase 2 1 Phase 3 1

Condition	Trials
Breast Cancer · Exemestane 25 MG for Breast Cancer	3
Breast Cancer Metastatic	1
ER-positive Breast Cancer	1
HER2-negative Breast Cancer	1
Hepatocellular Carcinoma (HCC)	1
Multiple sclerosis	1
Neuroendocrine Tumors	1
Renal Cell Carcinoma (RCC)	1
Stage IIB Breast Cancer	1
Stage III Breast Cancer	1
Tuberous Sclerosis Complex (TSC)	1

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 112 locations
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
NCT06364267 · Phase: Phase 2 · Ages: No age limits stated · Sex: Female · 1 location
Sapu003 in Advanced mTOR-sensitive Solid Tumors
NCT07369505 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations